Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiji Group Sichuan Mianyang Pharmaceutical is an operating pharmaceutical manufacturing subsidiary within Taiji Group, which is controlled by Sinopharm. The company is a long-established Chinese medicine manufacturer based in Mianyang, Sichuan, with historical roots traced by the company to 1851 and a formal corporate establishment in 1998. It manufactures a broad portfolio of commercialized medicines and health-related products, particularly traditional Chinese medicine products, and manages subsidiary Taiji Group Sichuan Tiancheng Pharmaceutical. The site has large-scale manufacturing capabilities across tablets, granules, pills, capsules, tinctures, topical products, oral liquids, syrups, ointments, disinfectants, and herbal extraction. Rather than a venture-style biotech with a disclosed R&D pipeline, it appears to be a mature commercial pharma manufacturing business centered on approved products, scale-up, and digitalized production operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiji Group Sichuan Mianyang Pharmaceutical.